EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Open Access

Dose finding, bioavailability, and PK-PD of oral triapine with concurrent chemoradiation for locally advanced cervical cancer and vaginal cancer (ETCTN 9892)

Sarah E Taylor, Sarah Behr, Kristine L Cooper, Haider Mahdi, Denise Fabian, Holly Gallion, Frederick Ueland, John Vargo, Brian Orr, Eugenia Girda, Madeleine Courtney-Brooks, Alexander B Olawaiye und 13 weitere

Cancer Chemotherapy and Pharmacology · 2025-12 · 95 (1)

DOI: 10.1007/s00280-024-04720-1 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Cancer Chemotherapy and Pharmacology, online erschienen am 14.12.2024. Verfasst von Sarah E Taylor und 24 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsb…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Chemoradiotherapy, Maximum Tolerated Dose, Pyridines. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, national cancer institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsChemoradiotherapyMaximum Tolerated DosePyridinesAntineoplastic Combined Chemotherapy ProtocolsBiological AvailabilityHumansFemaleMiddle AgedAgedAdultDose-Response Relationship, DrugAdministration, OralThiosemicarbazonesCisplatin

Stichwörter der Autor:innen

BioavailabilityDose findingPharmacodynamicsPharmacokineticsTriapine

Substanzen

3-aminopyridine-2-carboxaldehyde thiosemicarbazonePyridinesThiosemicarbazonesCisplatin

Autor:innen und Institutionen

  • Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. taylorse2@upmc.edu.
  • Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA. taylorse2@upmc.edu.
  • Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
  • Biostatistics Facility, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
  • Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Cancer Immunology Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.

ORCID-Profile: Jan H Beumer

Förderung

  • NCI NIH HHS
  • national cancer institute

Zitieren

APA

Taylor, S. E., Behr, S., Cooper, K. L., Mahdi, H., Fabian, D., Gallion, H., Ueland, F., Vargo, J., Orr, B., Girda, E., Courtney-Brooks, M., Olawaiye, A. B., Randall, L. M., Richardson, D. L., Sullivan, S. A., Huang, M., Christner, S. M., Beriwal, S., Lin, Y., …, & Beumer, J. H. (2025). Dose finding, bioavailability, and PK-PD of oral triapine with concurrent chemoradiation for locally advanced cervical cancer and vaginal cancer (ETCTN 9892). Cancer Chemotherapy and Pharmacology, 95(1). https://doi.org/10.1007/s00280-024-04720-1

Vancouver

Taylor SE, Behr S, Cooper KL, Mahdi H, Fabian D, Gallion H, et al. Dose finding, bioavailability, and PK-PD of oral triapine with concurrent chemoradiation for locally advanced cervical cancer and vaginal cancer (ETCTN 9892). Cancer Chemotherapy and Pharmacology. 2025;95(1). doi:10.1007/s00280-024-04720-1

BibTeX
@article{Taylor2025,
  author = {Taylor, Sarah E and Behr, Sarah and Cooper, Kristine L and Mahdi, Haider and Fabian, Denise and Gallion, Holly and Ueland, Frederick and Vargo, John and Orr, Brian and Girda, Eugenia and Courtney-Brooks, Madeleine and Olawaiye, Alexander B and Randall, Leslie M and Richardson, Debra L and Sullivan, Stephanie A and Huang, Marilyn and Christner, Susan M and Beriwal, Sushil and Lin, Yan and Chauhan, Aman and Chu, Edward and Kohn, Elise C and Kunos, Charles and Ivy, S Percy and Beumer, Jan H},
  title = {Dose finding, bioavailability, and PK-PD of oral triapine with concurrent chemoradiation for locally advanced cervical cancer and vaginal cancer (ETCTN 9892)},
  journal = {Cancer Chemotherapy and Pharmacology},
  year = {2025},
  volume = {95},
  number = {1},
  doi = {10.1007/s00280-024-04720-1}
}
Kostenlos starten →